131 related articles for article (PubMed ID: 6764859)
1. Bromocriptine in the treatment of the alcohol-withdrawal syndrome.
Borg V; Weinholdt T
Acta Psychiatr Scand; 1982 Feb; 65(2):101-11. PubMed ID: 6764859
[TBL] [Abstract][Full Text] [Related]
2. Double-blind controlled trial of bromocriptine, chlordiazepoxide and chlormethiazole for alcohol withdrawal symptoms.
Burroughs AK; Morgan MY; Sherlock S
Alcohol Alcohol; 1985; 20(3):263-71. PubMed ID: 3902038
[TBL] [Abstract][Full Text] [Related]
3. Bromocriptine therapy in cocaine withdrawal.
Giannini AJ; Baumgartel P; DiMarzio LR
J Clin Pharmacol; 1987 Apr; 27(4):267-70. PubMed ID: 3316308
[TBL] [Abstract][Full Text] [Related]
4. Double-blind comparison of bromocriptine and placebo in cocaine withdrawal.
Eiler K; Schaefer MR; Salstrom D; Lowery R
Am J Drug Alcohol Abuse; 1995 Feb; 21(1):65-79. PubMed ID: 7762545
[TBL] [Abstract][Full Text] [Related]
5. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.
Gallimberti L; Canton G; Gentile N; Ferri M; Cibin M; Ferrara SD; Fadda F; Gessa GL
Lancet; 1989 Sep; 2(8666):787-9. PubMed ID: 2571021
[TBL] [Abstract][Full Text] [Related]
6. Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence.
Tennant FS; Sagherian AA
Arch Intern Med; 1987 Jan; 147(1):109-12. PubMed ID: 3541819
[TBL] [Abstract][Full Text] [Related]
7. Bromocriptine in cocaine withdrawal--does it work?
Teller DW; Devenyi P
Int J Addict; 1988 Nov; 23(11):1197-205. PubMed ID: 3069753
[TBL] [Abstract][Full Text] [Related]
8. Bromocriptine and amantadine in cocaine detoxification.
Giannini AJ; Folts DJ; Feather JN; Sullivan BS
Psychiatry Res; 1989 Jul; 29(1):11-6. PubMed ID: 2672061
[TBL] [Abstract][Full Text] [Related]
9. Alcohol withdrawal syndrome: clinical and hormonal responses to alpha 2-adrenergic agonist treatment.
Cushman P; Sowers JR
Alcohol Clin Exp Res; 1989 Jun; 13(3):361-4. PubMed ID: 2568765
[TBL] [Abstract][Full Text] [Related]
10. Bromocriptine treatment of spasmodic torticollis. A double-blind crossover study.
Juntunen J; Kaste M; Iivanainen M; Ranta T; Seppälä M
Arch Neurol; 1979 Jul; 36(7):449-50. PubMed ID: 378199
[TBL] [Abstract][Full Text] [Related]
11. Effect of bromocriptine on the premenstrual syndrome. A double-blind clinical trial.
Andersen AN; Larsen JF; Steenstrup OR; Svendstrup B; Nielsen J
Br J Obstet Gynaecol; 1977 May; 84(5):370-4. PubMed ID: 329858
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine and premenstrual tension: a clinical and hormonal study.
Andersch B; Hahn L
Pharmatherapeutica; 1982; 3(2):107-13. PubMed ID: 7201645
[TBL] [Abstract][Full Text] [Related]
13. Alcohol withdrawal syndromes: clinical management with lofexidine.
Cushman P; Forbes R; Lerner W; Stewart M
Alcohol Clin Exp Res; 1985; 9(2):103-8. PubMed ID: 3890587
[TBL] [Abstract][Full Text] [Related]
14. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
[TBL] [Abstract][Full Text] [Related]
15. [Prolactin in the alcohol withdrawal syndrome. Role of the dopaminergic system].
Nardoni A; Marchetti E; Geatti O; Di Piazza V; Rossi G
Minerva Med; 1984 Dec; 75(47-48):2833-8. PubMed ID: 6521953
[TBL] [Abstract][Full Text] [Related]
16. The effects of bromocriptine in methyldopa treated hypertension.
Lewis MJ; Henderson AH
Br J Clin Pharmacol; 1980 Jan; 9(1):57-60. PubMed ID: 6986893
[TBL] [Abstract][Full Text] [Related]
17. Effects of 6-hydroxydopamine-induced lesions of A10 dopaminergic neurons and neuroleptic or bromocriptine treatment on ethanol withdrawal syndrome in rats.
Trzaskowska E; Puciłowski O; Kostowski W; Bidziński A
Pol J Pharmacol Pharm; 1983; 35(5):339-49. PubMed ID: 6141554
[TBL] [Abstract][Full Text] [Related]
18. Flumazenil in alcohol withdrawal.
Nutt D; Glue P; Wilson S; Groves S; Coupland N; Bailey J
Alcohol Alcohol Suppl; 1993; 2():337-41. PubMed ID: 7748321
[TBL] [Abstract][Full Text] [Related]
19. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome.
Walters AS; Hening WA; Kavey N; Chokroverty S; Gidro-Frank S
Ann Neurol; 1988 Sep; 24(3):455-8. PubMed ID: 3067654
[TBL] [Abstract][Full Text] [Related]
20. Effect of low-dose bromocriptine in treatment of psychosis: the dopamine autoreceptor-stimulation strategy.
Meltzer HY; Kolakowska T; Robertson A; Tricou BJ
Psychopharmacology (Berl); 1983; 81(1):37-41. PubMed ID: 6415730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
